Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medicine, these types of methods including a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging w